Aura Health is a global, vertically-integrated cannabis company focused on serving the medicinal markets in Europe. The company’s goal is to grow high-quality, low-cost flower in Israel, a leading jurisdiction in Europe’s medical cannabis industry. In Israel, Aura Health has partnered with HolyCanna Ltd., an Israel-based company with a cultivation and sales license application submitted to the Israeli Ministry of Health, and with CannabiSendak Ltd., an Israeli cannabis company founded by Israeli cannabis icon and activist Shlomi Sendak.
Aura Health also has a partnership with Nutritional High (CSE:EAT), which owns 12 percent of the company’s shares. This allows Aura to leverage its proprietary product development approach. David Posner (Chairman) and Vernon Frazier (COO), sit on Aura’s board of directors and bring a wealth of industry experience.
Aura Health’s company highlights include the following:
- Solidified strategic agreements with HolyCanna and CannabiSendak in Israel;
- HolyCanna initial operation of 50,000 square feet of grow with option to expand an additional 325,000 square feet;
- CannabiSendak to build its first high-profile dispensary in Tel Aviv, growing to 10,000 monthly patients;
- In discussions with various extraction companies in Europe;
- Strategic shareholder Nutritional High holds 12% of the company’s shares; and
- Aura’s management team and board hold 14% of the company’s shares.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).